Corium Drug Patent Portfolio
Corium owns 1 orange book drug protected by 9 US patents Given below is the list of Corium's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10966936 | Systems comprising a composite backing and methods for long term transdermal administration | 11 Aug, 2038 | Active |
| US10835499 | Systems and methods for long term transdermal administration | 20 May, 2038 | Active |
| US11648214 | Systems and methods for long term transdermal administration | 23 Sep, 2037 | Active |
| US10016372 | Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery | 26 Jul, 2037 | Active |
| US10300025 | Donepezil transdermal delivery system | 26 Jul, 2037 | Active |
| US10307379 | Donepezil transdermal delivery system | 26 Jul, 2037 | Active |
| US11103463 | Methods for treating alzheimer's disease with donepezil transdermal system | 26 Jul, 2037 | Active |
| US9993466 | Donepezil transdermal delivery system | 26 Jul, 2037 | Active |
| US11679086 | Systems comprising a composite backing and methods for long term transdermal administration | 26 May, 2037 | Active |
Latest Legal Activities on Corium's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Corium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 May, 2024 | US10835499 |
|
Electronic Review
Critical
| 26 Jun, 2023 | US11679086 |
|
Electronic Review
Critical
| 21 Jun, 2023 | US11679086 |
|
Email Notification
Critical
| 21 Jun, 2023 | US11679086 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Jun, 2023 | US11679086 |
| Recordation of Patent eGrant | 20 Jun, 2023 | US11679086 |
| Patent eGrant Notification | 20 Jun, 2023 | US11679086 |
| Mail Patent eGrant Notification | 20 Jun, 2023 | US11679086 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Jun, 2023 | US11679086 |
|
Electronic Review
Critical
| 01 Jun, 2023 | US11679086 |
|
Email Notification
Critical
| 01 Jun, 2023 | US11679086 |
|
Issue Notification Mailed
Critical
| 31 May, 2023 | US11679086 |
|
Email Notification
Critical
| 23 May, 2023 | US10016372 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 22 May, 2023 | US10016372 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 22 May, 2023 | US10300025 |
Corium's Family Patents
Corium drugs have patent protection in a total of 11 countries. It's US patent count contributes only to 38.2% of its total global patent coverage. Click
below to unlock the full patent family tree.
Corium Drug List
Given below is the complete list of Corium's drugs and the patents protecting them.
1. Adlarity
Adlarity is protected by 9 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10966936 | Systems comprising a composite backing and methods for long term transdermal administration |
11 Aug, 2038
(13 years from now)
| Active |
| US10835499 | Systems and methods for long term transdermal administration |
20 May, 2038
(13 years from now)
| Active |
| US11648214 | Systems and methods for long term transdermal administration |
23 Sep, 2037
(12 years from now)
| Active |
| US10016372 | Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery |
26 Jul, 2037
(12 years from now)
| Active |
| US10300025 | Donepezil transdermal delivery system |
26 Jul, 2037
(12 years from now)
| Active |
| US10307379 | Donepezil transdermal delivery system |
26 Jul, 2037
(12 years from now)
| Active |
| US11103463 | Methods for treating alzheimer's disease with donepezil transdermal system |
26 Jul, 2037
(12 years from now)
| Active |
| US9993466 | Donepezil transdermal delivery system |
26 Jul, 2037
(12 years from now)
| Active |
| US11679086 | Systems comprising a composite backing and methods for long term transdermal administration |
26 May, 2037
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adlarity's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List